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Abstract
Introduction: Data sharing in clinical research is critical for increasing knowledge discovery. Data
and software tools should be FAIR: Findable, Accessible, Inter-operable and Re-usable. Many
bottlenecks exist in the process of a clinical investigator using shared data including data acquisition
and statistical analysis. The objective of this project is to develop a structure for sharing data and
providing rapid automated statistical analysis through creation of a pre-packaged, open-source
software container.
Methods: We use the open source software container technologies VirtualBox and Vagrant to create
a template for sharing clinical data and analysis scripts as a single container. We use a timer to
record the time necessary to setup and initialize the software container and view the results.
Results: We have created a template for sharing data and analysis scripts together using open
source software container technologies VirtualBox and Vagrant. We found the time needed to
initialize the container to be 5 minutes and 36 seconds for a macOS-based machine and 7 minutes
and 2 seconds for a Windows-based machine. Containers can be downloaded and executed from
any Mac or Windows computer allowing both the reuse of and interaction with the data. This greatly
reduces the time and effort needed to obtain and analyze clinical data.
Conclusion: Reducing the time and effort needed to obtain and analyze clinical data increases
the time available for data exploration and the discovery of new knowledge. This can be effectively
achieved using software containers and virtualization.
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Introduction
For many years, there has been a growing need for data
management standards for the sharing and reuse of research
data. Public data sharing policies have been a part of
government funded research for many years [1], and several
organizations have recently reiterated this importance as
technologies continue to make data more accessible [2-5]. Data
collected and generated by investigators is often stored in an
ad-hoc fashion, with a structure that is clear and consistent to
the investigator and research team, but not necessarily by those
who may be interested in its reuse. This is especially important
to public and private funding organizations, where data are
the product of an investment and must continue to have value
into the future. “Data stewardship” is a common term used to
describe this new trend for researchers structuring their data to
support future use.
Recently, the NIH and other public funding bodies have adopted
the FAIR principles [6] as a general guideline for the necessary
features needed to facilitate data sharing. These features include
Findability, Accessibility, Interoperability, and Reusability. In
this paradigm, not only is it important that data be structured
for reuse by other investigators, but also structured for machine
*Correspondence To: William A Mattingly, PhD
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and software interfaces as well. More and more data are being
accessed by software data mining and discovery platforms, and
each requires consistent and standardized data structures to be
effective at knowledge discovery. Fortunately, data structures
designed to be machine-readable can be enhanced to support
human readability as well. The development and adoption of
these new standards will be a recurring theme in the future of
research.
In addition to making raw research data accessible, FAIR
principles are intended to apply to the software that researchers
use to analyze their datasets. This has led to the concepts of
data authorship and research objects. [7, 8] Research objects
can include the analysis software code used to generate results
in addition to the dataset itself. Creating these structures can
be challenging in terms of time spent by investigators [9]. It
is also cumbersome to make shared software analysis code
reusable. The efficient reuse of software source code is a focus
of the discipline of software engineering [10], and effort must be
invested by programmers early in the development process for
software to be reusable. Without this effort, it takes more time to
understand the intent of the original programmer than to write
a new program. Modern programming languages have made it
easier to apply the principles of software reuse and even novice
programmers can now develop software that is easy to extend,
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modify, and reuse [11]. In the area of clinical research, following
FAIR principles continues to be a challenge. Furthermore, little
work has been done to make it simple for clinical investigators
to use these principles in obtaining and analyzing their data.
From informal interviews with pneumonia researchers and
statisticians we found several obstacles to creating shared
datasets in this field. Two obstacles stand out from the others.
The first was the difficulty in giving the data the appropriate
context to be interpreted accurately by subsequent investigators.
This context can consist of the specific features of the study
population, the conditions under which the data was collected,
and the types of research questions the data was gathered
to answer. The second major obstacle is the time and effort
needed to replicate the analysis pipeline used by the primary
investigator. These pipelines can be very sophisticated and their
setup can be time consuming to replicate. If this setup could be
automated it could improve the ability of shared data to be used
by others.
Our objective was to improve the utility of shared datasets
by creating a fast and easy to use software container for
sharing research data and statistical analyses. This container
will support the FAIR principles of findability, accessibility,
interoperability, and reusability. We record the startup time
needed for the software container and describe the steps
necessary for its setup and execution. The container will also
support the addition of contextual information about the data in
the form of documentation and commentary from the creators.
Terms and Abbreviations
OS - operating system
virtual machine
FAIR
data stewardship
virtualization
VirtualBox
open source software
Vagrant
R
Linux
proprietary software

The software for managing interactive
programs on a computer.
Software that partitions physical hardware
into virtual hardware that can run contained
software environments.
Findable, Accessible, Interoperable, Reusable
The facilitation of data re-use by researchers
and investigators
the process of running software inside a
virtual machine
An open source software virtualization
program
Software that is made freely available with
little to no licensing restrictions
open source virtual machine management
software
An open source programming language
supporting many statistical tests
A popular open source operating system
software that has licensing restrictions
governing its use and distribution

Methods
Data used in this study originate from the University of
Louisville Pneumonia Study, a three-year study on the
incidence, epidemiology, and clinical outcomes of hospitalized
patients with community-acquired pneumonia[12]. This study
took place from June 1, 2014 to March 31, 2017.
When designing the software container, we set out to address
each of the four FAIR principles to the best of our ability. How
an investigator addresses FAIR principles when sharing data
will depend upon many factors, such as the type of data being
shared and the type of software used to analyze data. For these
reasons, the methods used for this study may not translate in
their entirety to other studies. We describe below the FAIR
principle and how it was addressed.
1.

Findability: Data should be easy to find. For this study we

2.

3.

4.

used Zenodo[13], a free online service funded by CERN[14]
to generate a DOI or permanent document object identifier,
for our dataset and software container. Zenodo registers
DOIs through DataCite, and provides means for updating
and retracting incorrect data[15].
Accessibility: Data should be easy to access. Our data is deidentified and will be hosted online along with the software
container. Any user with an internet connection can access
it.
Interoperability: Data should be in a standardized format.
We share our data in a comma separated value file with a
header row describing the variable name. This is a common
standard for clinical data analysis.
Reusability: Data should be reusable. We believe a
software container is a viable method for addressing this
principle, as it will quickly provide the means to explore
shared data for secondary analyses.

To develop the software container, we use several opensource applications. First, to pre-package an operating system
for use on any machine, we used two open source software
virtualization solutions: VirtualBox[16] and Vagrant[17].
VirtualBox is a software virtualization environment that is
designed to manage guest operating systems running within a
primary host operating system. It’s one of many technologies
designed to perform this task, with other notable examples
being Microsoft’s Hyper-V and Dell’s VMWare. The primary
benefit of software virtualization is the ability to quickly and
easily replicate the operating conditions of software without
needing to replicate their expensive hardware environment.
This allowed us to create a virtual computer, containing data and
automated analysis scripts in a single container that can be run
through another computer, regardless of the operating system
(e.g. Microsoft Windows, Apple macOS, etc.). VirtualBox is the
most widely used open source virtualization software and is
used in health informatics for security and performance testing,
but is being used more and more for the packaging of data and
analysis pipelines for reuse [18, 19]. Vagrant is a virtualization
management software designed to simplify the organization and
description of virtual machine environments. Vagrant facilitates
storing a robust description of the entire software environment
needed to perform a given task. This software makes it easier for
investigators to open the virtual machine and visualize results
of their analysis. This software allowed us to encapsulate the
dataset and the analytical software needed to perform analysis.
In these environments, the dataset is stored in a comma
separated values (.csv) file, allowing easy access by analytical
software. This standard file format is also readable into any
spreadsheet program and requires minimal electronic storage
space. This was desirable to limit the processing and memory
overhead required by the virtual machine, allowing for more
processing power to be devoted to the analysis engine.
Statistical analysis scripts were written in the R environment
[20]. This is an open-source software commonly used for
highlevel statistical analysis. Common analyses used by clinical
investigators were re-created in this programming environment
and packaged along with R version 3.3.2 and the clinical data
inside of the virtual machine.
In the case of data sharing, the data and analysis scripts are
stored in a folder along with a virtual machine description.
When the machine is initiated using Vagrant, the dataset and
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analysis scripts are loaded into the guest environment and the
virtual machine is ready to perform the analysis and display
results. A diagram of this structure is illustrated in Figure 1.

Data Object Template
Object
Description
File

Virtual Machine
Operating System (guest)

Data File

Statistical
Software

Source Code

Data File Copy

Fig. 1. Diagram of the data object template. Included with the data is the
Object Description File, containing the configuration information needed
to replicate the analysis environment, including the statistical software
(R) and analysis source code.

The steps necessary to open the virtual machine and perform
analysis are summarized as follows:
1. Ensure that Vagrant and VirtualBox are downloaded and
installed on the local machine.
2. Download the Data Container and unzip into a directory (e.g.
Computer desktop).
3. Double click on the startup file in the directory corresponding
to your operating system (Microsoft Windows or Apple
macOS).
The virtual machine initializes its startup sequence before
loading the statistical programming environment and executing
the packaged analysis script. At this point a user familiar with
the R analysis software can explore the automatically loaded
dataset and perform analysis.
This process was tested using the University of Louisville
Pneumonia Study lactic acid dataset. The lactate study featured
3658 patients enrolled from June 1, 2014 to May 31, 2016.
Lactate levels were associated with higher in-hospital mortality,
with patients having ≥4 mmol/L of lactic acid having a nearly
a 3-fold increase in odds of dying during hospitalization. The
dataset is available for download[21]. The analysis scripts
performed for this study included:
1.

2.

3.
4.

aggregate descriptive analyses (frequency with percent for
categorical variables and mean with standard deviation for
continuous variables),
bivariable comparisons of patient characteristics between
those with and without lactate levels of ≥4 mmol/L using
student’s t-tests for continuous variables and Chi-squared
tests for categorical variables,
univariable logistic regression for calculation of unadjusted
odds ratios, and
multivariable logistic regression for calculation of adjusted
odds ratios comparing the adjusted odds of in-hospital
mortality for those with and without lactate levels of ≥4
mmol/L.

Apple macOS.
Table 1. Variable names and descriptions.
Variable
age

Description
Categorized Age in Years

Coding

sex

Sex

nursinghome
neoplastic
liver
chf
cvd
renal
mental
hr125
rr30
sbp90
templow
temphigh
ph735
bun30
na130
gluc250
hematocrit30
pao260
peﬀusion
copd
diabetes
icudirect
imv
vaso
psi4or5
curb4or5

Nursing Home Resident
History of Neoplastic Disease (past year)
History of Liver Disease
History of Congestive Heart Failure
History of Cerebrovascular Disease
History of Renal Disease
Altered Mental Status on admission
Heart Rate > 125 beats/minute
Respiratory Rate >30 breaths/minute
Systolic Blood Pressure < 90 mmHg
Temperature <35 degrees C
Temperature >= 40 degrees C
Arterial pH <7.35
Blood Urea Nitrogen >=30 mg/dl
Sodium <130 mmol/L
Glucose >=250 mg/dl
Hematocrit < 30%
Partial pressure of arterial O2 <60 mmHg
Pleural eﬀusion present
History of COPD
History of Diabetes
Patient admitted directly to ICU
Invasive mechanical ventilation on day 0
Vasopressors taken on day 0
Pneumonia Severity Risk Class IV or V
CURB-65 score 4 or 5

lactate

Lactate level

ihm
clinical_failure
los
los_yn
tcs
tcs_yn

In-hospital mortality
Clinical Failure within two weeks of admission
Length of Stay (in days)
Patient discharged within 2 weeks
Time to clinical stability (in days)
Patient clinically stable within 1 week

1=Male
0=Female
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
0= <2 mmol/L
1= 2-4 mmol/L
2= ≥4 mmol/L
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No
1=Yes 0=No

Results
Host machine specifications and display times are shown in
Table 2. The first startup time includes the time needed to
download the initial virtual machine operating system, which
will vary depending on many factors such as connection speed
and network congestion. If the user shuts down the virtual
machine after interacting with data, subsequent changes to the
system will be much faster as shown in the subsequent startup
time column. The large time difference in the two compared
operating systems is due to the solid-state storage technology
used in all new Apple computers, and not available in the
Windows Server used in this study. A Windows system with
solid state technology would have comparable startup times to
the Apple system.

Table 2. Startup times for the software container on macOS and
Windows platforms
Machine
Apple macOS MacBook Pro:
2Ghz i5 dual core
16GB Memory
Microsoft Windows Server 2012
Dell PowerEdge 610:
2.5Ghz i5 quad core
96GB Memory

First Startup Time
5m:36s

Subsequent Startup Times
0m:31s

7m:02s

2m:56s

The variable names and descriptions are shown in Table 1.
We record the time needed to display analysis results for this
dataset on two different host platforms: Microsoft Windows and

ULJRI Vol 1, (4) 2017

26

The process of the virtual machine after downloading and
installing is as follows, assuming the free Vagrant and VirtualBox
software have also already been installed. First, the system will
download a free Linux environment called Ubuntu [22]. After
this has been downloaded, the virtual machine boots and starts
downloading the current R software needed to perform analysis.
Because R includes many different libraries needed to perform
various analyses, this typically requires 2-3 minutes. Once the
installation and configuration of R is complete, the user will be
in the R command line environment and the system will have
executed the output of the packaged study analysis. The results
of the analysis is shown in Figures 2 and 3.

Discussion
To our knowledge, this study was the first of its kind to create a
pre-packaged software container for data sharing and automated
statistical analysis of clinical research data. The open-source
software used makes the container free and readily usable by all
individuals with a computer and internet access. The container
opens and installs rapidly, and provides automated output for
results.
We believe that including the statistical software environment
used to produce the results for a study dataset is an important
contribution to data sharing and data authorship. We have
developed a template for this type of data sharing for which the
setup time needed to see and interact with results is negligible.
Providing the details of an analysis exactly as they were
performed is valuable to original study investigators and those
wanting to perform secondary analyses.
The nature of data sharing is constantly changing and the most
effective requirements are still an item of debate [23-27]. It is
generally agreed that data sharing plans are beneficial to all
research stakeholders, but the most cost-effective way to achieve
data sharing is still unclear. The argument is often made that
the only way to overcome the cost obstacles of data sharing
requirements is to take advantage of a highly-centralized
system with robust and standardized requirements for data and
metadata. Systems like these are emerging and include: Yale
Open Data Access (YODA) [28] and the Supporting Open Access
for Researchers (SOAR) initiative [29] , but it is not clear how
these data repositories will work together without an industry
backed standard.

Fig. 2. Screenshot of the generated patient characteristics table for the
University of Louisville Pneumonia Study Lactic Acid dataset.

Fig. 3. A screenshot of the univariable and multivariable logistic
regression output of the virtual machine.

Another major concern for data sharing is fairness regarding
differences in research infrastructure [30]. Countries and
organizations with well-established research infrastructure are
better equipped to discover knowledge from shared data sets.
They will usually have strong analysis pipelines and trained
biostatisticians and epidemiologists available to perform
secondary analysis on collected and curated data. This may lead
to the marginalization of smaller research groups who play an
important role in collecting and providing data to the research
community.
Further issues with data sharing include secondary investigators
using shared data and publishing their results without
acknowledgment of the initial research team. This issue often
results in hesitation to share data. A more recent data sharing
strategy suggests that authorship could be associated with
a published dataset [31]. This allows the investigators and
team responsible for collecting and curating a set of clinical
data to publish it online in a public data repository. The data
authors can then be referenced in publications by the original
investigators themselves or by collaborators and secondary
investigators. This allows original investigators to get the credit
they deserve for studies that can be difficult to plan, set up,
and manage. Many collaborative organizations are forming to
try to mitigate the problem involving credit for secondary data
use. The Community Acquired Pneumonia Organization [32]
was established to facilitate advances in pneumonia research
through collaboration and data sharing. Other groups include
the Infectious Diseases Data Observatory [33], the Worldwide
Anti-malarial Resistance Network [34], the National Surgical
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Adjuvant Breast and Bowel Project [35] and many others.
The benefits of such organizations are substantial and include
development of better research questions and clear mission
goals for produced research. One drawback is that while data
will be consistent within such groups, a common data standard
is needed to support true multidisciplinary collaboration.
There are several limitations to this study. First, The process
we describe shifts some technical burden from a secondary
investigator to the original investigators. There are many
options available for packaging data objects and investigators
will need to decide the most efficient means of data stewardship.
Ultimately, we believe data stewardship and data authorship
efforts will become formalized in an endorsed standard, making
the creation process more streamlined and easy. Until that time,
investigators should endeavor to follow FAIR principles to the
best of their ability and make the data they share as accessible as
possible. Second, the setup process will be specific to the type of
operating system a secondary investigator is using. An effective
container will support the three major operating systems,
Windows, macOS, and Linux, but this greatly increases the
work investment for investigators. Because of the similarities
between macOS and Linux, supporting Windows and macOS
is generally sufficient as they comprise 94.05 percent of the
operating system market share in 2017[36]. Thirdly, it is always
possible that secondary users will be able to misinterpret share
data or the results of analysis. We have tried to mitigate this
as much as possible by providing comments in the analysis
software code and in the output of results.

Conclusion

2.
3.
4.

5.
6.

7.

8.

9.

10.
11.
12.

We have described a data container capable of effectively
sharing data along with the software code used to arrive
at publishable results. In the future graphical plots should
be added to data objects as they are an important part
of understanding the results of research. We intend to
develop software containers that quickly display graphical
representations from within a data object. Possible means
include packaging an interactive web environment with the
data object or using the windowing interface of the host
machine to display plots from the guest machine. Although
the primary goal of this project was to outline how data
can be shared and pre-packaged in an automated analysis
environment, we believe this can also add to the transparency
and reproducibility of clinical research findings through
creation of software containers for results published in peerreviewed journals or on clinicaltrials.gov. This increased
transparency and facilitation of data sharing can enhance high
quality research and translate into better patient care.
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